QA: Dianthus Therapeutics Inc. DE in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001690585_2021_Dianthus_Therapeutics_Inc_DE.pdf

Logs

Graph

Absolute values for 0001690585, Dianthus Therapeutics Inc. DE

  xvar xval
0 AssetsCurrent 151,527,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 8,312,000
3 remainder_Assets 1,780,000
4 LiabilitiesCurrent 11,430,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 6,283,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 28,087,000
9 ResearchAndDevelopmentExpense 50,615,000
10 remainder_Expenses 0
11 remainder_Revenues 3,766,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -31,000
  yvar yval
0 Assets 161,619,000
1 Liabilities 17,713,000
2 Expenses 78,702,000
3 Revenues 3,766,000
4 StockholdersEquity 143,906,000
5 NetIncome -74,936,000
6 ComprehensiveNetIncome -74,951,500
7 BaseVar 130,915,500
8 EconomicCapitalRatio 1.92

Edgar->Model Mapping

Feature Distribution

Change over Time